Does a Mandatory Non-Medical Switch From Originator to Biosimilar Infliximab Lead to Increased Use of Outpatient Healthcare Resources? A Register-Based Study in Patients With Inflammatory Arthritis

RMD Open - United Kingdom
doi 10.1136/rmdopen-2018-000710
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ